[1]倪文丽,唐慧琴,雷铭德,等.膀胱癌专病科研数据库建设与应用[J].医学信息,2023,36(07):31-35.[doi:10.3969/j.issn.1006-1959.2023.07.006]
　NI Wen-li,TANG Hui-qin,LEI Ming-de,et al.Construction and Application of Scientific Research Database for Bladder Cancer[J].Journal of Medical Information,2023,36(07):31-35.[doi:10.3969/j.issn.1006-1959.2023.07.006]
点击复制

膀胱癌专病科研数据库建设与应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年07期
页码:
31-35
栏目:
卫生管理信息学
出版日期:
2023-04-01

文章信息/Info

Title:
Construction and Application of Scientific Research Database for Bladder Cancer
文章编号:
1006-1959（2023）07-0031-05
作者:
倪文丽; 唐慧琴; 雷铭德; 等
（天津市医科大学第二医院泌尿外科研究所1，泌尿外科2，天津 300202）
Author(s):
NI Wen-li; TANG Hui-qin; LEI Ming-de; et al.
(Institute of Urology1,Department of Urology2,the Second Hospital of Tianjin Medical University,Tianjin 300202,China)
关键词:
膀胱癌; 专病数据库; 自然语言处理; 疾病数据集
Keywords:
Bladder cancer; Disease-specific database; Natural language processing; Disease dataset
分类号:
R737.14
DOI:
10.3969/j.issn.1006-1959.2023.07.006
文献标志码:
B
摘要:
基于医院信息化平台建设膀胱癌专病科研数据库，通过自然语言处理技术实现专病临床数据的结构化和标准化，构建一个符合临床和科研的高质量、一体化的膀胱癌专病数据库。该数据库可以实现智能病例检索、患者科研全景、科研项目管理、定制化应用等功能，有效支撑医生的临床研究工作。本文针对该数据库的系统架构、数据集、数据整合及其应用情况进行了总结。
Abstract:
To build a scientific research database of bladder cancer based on hospital information platform, and realize the structure and standardization of specific clinical data through natural language processing technology, so as to construct a high-quality and integrated bladder cancer specific disease database in line with clinical and scientific research. The database can realize intelligent case retrieval, patient research panorama, scientific research project management, customized application and other functions, and effectively support the clinical research work of doctors. This paper summarizes the system architecture, data sets, data integration and application of the database.

参考文献/References:

[1]Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.[2]李辉章,郑荣寿,杜灵彬,等.中国膀胱癌流行现状与趋势分析[J].中华肿瘤杂志,2021,43(3):293-298.[3]Okorie CL,Gatsby E,Schroeck FR,et al.Using electronic health records to streamline provider recruitment for implementation science studies[J].PLoS One,2022,17(5):e0267915.[4]Wu WT,Li YJ,Feng AZ,et al.Data mining in clinical big data: the frequently used databases, steps, and methodological models[J].Mil Med Res,2021,8(1):44.[5]李慧杰,张晴晴,刘瑞红,等.大数据背景下临床专病数据库建设实践与思考[J].中国卫生事业管理,2020,37(8):574-576,591.[6]宓林晖,潘常青,袁骏毅,等.心衰专病数据库的建设与应用[J].微型电脑应用,2022,38(2):12-15.[7]李岳峰,胡建平,庹兵兵,等.我国卫生健康信息标准建设成效与思考[J].中国卫生信息管理杂志,2021,18(3):324-329.[8]El-Khayat YM,Forbes CS,Coghill JG.Guideline.gov: A Database of Clinical Specialty Guidelines[J].Med Ref Serv Q,2017,36(1):62-72.[9]尚诗,袁骏毅,岑星星.基于EMPI心肌病专病数据库的构建[J].中国医疗设备,2022,37(6):115-118.[10]靳英辉,曾宪涛.中国非肌层浸润性膀胱癌治疗与监测循证临床实践指南(2018年标准版)[J].现代泌尿外科杂志,2019,24(7):516-542.[11]Flaig TW,Spiess PE,Agarwal N,et al.Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology[J].J Natl Compr Canc Netw,2020,18(3):329-354.[12]Witjes JA,Bruins HM,Cathomas R,et al.European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines[J].Eur Urol,2021,79(1):82-104.[13]Babjuk M,Burger M,Capoun O,et al.European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta,T1,and Carcinoma in Situ)[J].Eur Urol,2022,81(1):75-94.[14]杜小勇,陈跃国,范举,等.数据整理——大数据治理的关键技术[J].大数据,2019,5(3):13-22.[15]刘迷迷,杜国霞,周毅,等.专病数据库建设与应用研究[J].医学信息学杂志,2021,42(11):81-86,93.[16]罗辉,薛万国,乔屾.大数据环境下医院科研专病数据库建设[J].解放军医学院学报,2019,40(8):713-718.[17]王昳佳.大数据时代背景下医院数据中心建设的相关思考[J].电脑知识与技术,2020,16(3):9-10.[18]孙颖,李超峰,林丽,等.鼻咽癌专病科研数据库建设与应用[J].中国数字医学,2021,16(1):7-12.[19]王飞,黄艺璠,汪鹏.基于多模态数据的肺癌专病库建设研究[J].中国数字医学,2021,16(12):85-88,104.

相似文献/References:

[1]刘 坤,陈德春.基于生信学方法分析GSDM基因家族在膀胱癌的表达及临床意义[J].医学信息,2022,35(10):14.[doi:10.3969/j.issn.1006-1959.2022.10.003]
　LIU Kun,CHEN De-chun.Expression and Clinical Significance of GSDM Gene Family in Bladder Cancer Based on Bioinformatics Analysis[J].Journal of Medical Information,2022,35(07):14.[doi:10.3969/j.issn.1006-1959.2022.10.003]
[2]幸世玉.经尿道电切术联合吉西他滨灌注治疗膀胱癌的临床效果分析[J].医学信息,2018,31(20):91.[doi:10.3969/j.issn.1006-1959.2018.20.026]
　XING Shi-yu.Clinical Analysis of Transurethral Resection Combined with Gemcitabine Perfusion in the Treatment of Bladder Cancer[J].Journal of Medical Information,2018,31(07):91.[doi:10.3969/j.issn.1006-1959.2018.20.026]
[3]熊波波,张劲松,王海峰,等.miRNAs与泌尿系肿瘤关系的研究进展[J].医学信息,2019,32(05):35.[doi:10.3969/j.issn.1006-1959.2019.04.013]
　XIONG Bo-bo,ZHANG Jin-song,WANG Hai-feng,et al.Research Progress on the Relationship between miRNAs and Urinary Tumors[J].Journal of Medical Information,2019,32(07):35.[doi:10.3969/j.issn.1006-1959.2019.04.013]
[4]郝保良.等离子针状电极剜切治疗非肌层浸润性膀胱癌的效果[J].医学信息,2021,34(04):148.[doi:10.3969/j.issn.1006-1959.2021.04.040]
　HAO Bao-liang.Effect Plasma Needle Electrode Enucleation for Non-muscular Invasive Carcinoma of Urinary Bladder[J].Journal of Medical Information,2021,34(07):148.[doi:10.3969/j.issn.1006-1959.2021.04.040]
[5]杜国望,陈 昊,苗岳松,等.保留膀胱综合疗法治疗肌层浸润性膀胱癌的效果[J].医学信息,2020,33(06):122.[doi:10.3969/j.issn.1006-1959.2020.06.038]
　DU Guo-wang,CHEN Hao,MIAO Yue-song,et al.Effect of Bladder-preserving Comprehensive Therapy on Muscular Invasive Bladder Cancer[J].Journal of Medical Information,2020,33(07):122.[doi:10.3969/j.issn.1006-1959.2020.06.038]
[6]张晓伟,陈 明,田谋利,等.术中体位变化和气腹对机器人辅助腹腔镜根治性膀胱切除患者眼压的影响[J].医学信息,2020,33(14):113.[doi:10.3969/j.issn.1006-1959.2020.14.034]
　ZHANG Xiao-wei,CHEN Ming,TIAN Mou-li,et al.Effects of Intraoperative Posture Changes and Pneumoperitoneum on Intraocular Pressure in Patients with Robot-assisted Laparoscopic Radical Cystectomy[J].Journal of Medical Information,2020,33(07):113.[doi:10.3969/j.issn.1006-1959.2020.14.034]
[7]熊 雄,熊 斌,姚 烽.CYFRA21-1与BTA stat检测在膀胱癌诊断中的应用价值[J].医学信息,2020,33(22):104.[doi:10.3969/j.issn.1006-1959.2020.22.029]
　XIONG Xiong,XIONG Bin,YAO Feng.Application Value of CYFRA21-1 and BTA Stat in the Diagnosis of Bladder Cancer[J].Journal of Medical Information,2020,33(07):104.[doi:10.3969/j.issn.1006-1959.2020.22.029]
[8]孙祖刚,王咸钟,谢习颂,等.慢性炎症分子基础及信号通路在膀胱癌中的作用[J].医学信息,2020,33(19):31.[doi:10.3969/j.issn.1006-1959.2020.19.010]
　SUN Zu-gang,WANG Xian-zhong,XIE Xi-song,et al.The Molecular Basis of Chronic Inflammation and the Role of Signal Pathways in Bladder Cancer[J].Journal of Medical Information,2020,33(07):31.[doi:10.3969/j.issn.1006-1959.2020.19.010]
[9]任默涵,于东海,吴 迪.MTHFD2基因在膀胱癌中的表达、功能富集及信号通路的生物信息学分析[J].医学信息,2022,35(24):18.[doi:10.3969/j.issn.1006-1959.2022.24.004]
　REN Mo-han,YU Dong-hai,WU Di.Expression, Functional Enrichment and Bioinformatics Analysis of MTHFD2 Gene in Bladder Cancer[J].Journal of Medical Information,2022,35(07):18.[doi:10.3969/j.issn.1006-1959.2022.24.004]
[10]苗岳松,刘 杰,刘 昕,等.循环肿瘤细胞在膀胱癌诊疗中的应用价值[J].医学信息,2021,34(08):72.[doi:10.3969/j.issn.1006-1959.2021.08.019]
　MIAO Yue-song,LIU Jie,LIU Xin,et al.The Application Value of Circulating Tumor Cells in the Diagnosis and Treatment of Bladder Cancer[J].Journal of Medical Information,2021,34(07):72.[doi:10.3969/j.issn.1006-1959.2021.08.019]

更新日期/Last Update: 1900-01-01